Lin Y, Walker A, Batta M, Ottilie-Kovelman S, Duchenko A, Brugger C
BMJ Public Health. 2025; 2(1):e000441.
PMID: 40018115
PMC: 11816951.
DOI: 10.1136/bmjph-2023-000441.
Wang J, Yu L, Yang Z, Shen P, Sun Y, Shui L
Int J Epidemiol. 2025; 54(2).
PMID: 39993264
PMC: 11849956.
DOI: 10.1093/ije/dyae174.
Byrne A, Al-Hindawi Y, Plit M, Yeung L, Rigava S, King M
BMC Pulm Med. 2025; 25(1):84.
PMID: 39984904
PMC: 11846343.
DOI: 10.1186/s12890-025-03549-5.
Oh K, Morishita F, Rahevar K, Yadav R, Tran H, Marks G
IJTLD Open. 2025; 2(2):64-72.
PMID: 39959399
PMC: 11827672.
DOI: 10.5588/ijtldopen.24.0608.
Delrue C, De Bruyne S, Speeckaert M
Diagnostics (Basel). 2025; 15(3).
PMID: 39941298
PMC: 11818004.
DOI: 10.3390/diagnostics15030368.
"You find yourself in a very humiliating situation": experiences of people living with post-tuberculosis lung disease in Brazil.
de Almeida C, Furin J, Sumiya A, Silva D, Mitnick C
Front Public Health. 2025; 12():1431881.
PMID: 39776473
PMC: 11703962.
DOI: 10.3389/fpubh.2024.1431881.
Clinical-Epidemiological Profile of Patients With Chronic Obstructive Pulmonary Disease Treated at the Pneumology Outpatient Clinic of a Brazilian University Hospital.
Sarno Filho M, Soares L, Lima Costa Neves M
Cureus. 2024; 16(12):e75451.
PMID: 39677991
PMC: 11646360.
DOI: 10.7759/cureus.75451.
Comorbidities and Treatment Outcomes in Patients Diagnosed with Drug-Resistant Tuberculosis in Rural Eastern Cape Province, South Africa.
Hosu M, Faye L, Apalata T
Diseases. 2024; 12(11).
PMID: 39589970
PMC: 11593127.
DOI: 10.3390/diseases12110296.
The Incidence, Risk Factors, and Predictive Model of Obstructive Disease in Post-Tuberculosis Patients.
Chang W, Li Z, Liang Q, Zhao W, Li F
Int J Chron Obstruct Pulmon Dis. 2024; 19:2457-2466.
PMID: 39588458
PMC: 11586266.
DOI: 10.2147/COPD.S489663.
Identification of Post-Tuberculosis Lung Function Impairment Early during the Course of Treatment.
Musa B, Dankishiya F, Babashani M, Musa A, Saidu H, Saleh M
Am J Trop Med Hyg. 2024; 112(1):143-149.
PMID: 39531728
PMC: 11720773.
DOI: 10.4269/ajtmh.24-0137.
Characteristics of Pulmonary Inflammation in Patients with Different Forms of Active Tuberculosis.
Shepelkova G, Evstifeev V, Berezovskiy Y, Ergeshova A, Tarasov R, Bagirov M
Int J Mol Sci. 2024; 25(21).
PMID: 39519346
PMC: 11546853.
DOI: 10.3390/ijms252111795.
Audit of risk factors of drug-sensitive, drug-resistant tuberculosis disease, a case-control study of patients registered under NTEP, Gujarat.
Shah V, Yogesh M, Kothari D, Gandhi R, Nagda J
J Family Med Prim Care. 2024; 13(9):3614-3620.
PMID: 39464923
PMC: 11504741.
DOI: 10.4103/jfmpc.jfmpc_1967_23.
Mortality Rates after Tuberculosis Treatment, Georgia, USA, 2008-2019.
Gorvetzian S, Pacheco A, Anderson E, Ray S, Schechter M
Emerg Infect Dis. 2024; 30(11):2261-2270.
PMID: 39447141
PMC: 11521157.
DOI: 10.3201/eid3011.240329.
Characterization of non-tuberculous mycobacterial pulmonary disease and pulmonary tuberculosis in patients with AFB smear-positive sputum: A retrospective comparative study.
Li X, Sun D, Liang C, Gu W
Heliyon. 2024; 10(17):e37434.
PMID: 39295993
PMC: 11409140.
DOI: 10.1016/j.heliyon.2024.e37434.
Tuberculosis-Associated Respiratory Disability in Children, Adolescents, and Adults: Protocol for a Systematic Review and Individual Participant Data Meta-Analysis.
Chiang S, Romanowski K, Johnston J, Petiquan A, Bastos M, Menzies D
medRxiv. 2024; .
PMID: 39281764
PMC: 11398436.
DOI: 10.1101/2024.09.03.24313003.
ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis.
Chacko B, Chaudhry D, Peter J, Khilnani G, Saxena P, Sehgal I
Indian J Crit Care Med. 2024; 28(Suppl 2):S67-S91.
PMID: 39234233
PMC: 11369919.
DOI: 10.5005/jp-journals-10071-24783.
Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis.
Hamada Y, Quartagno M, Malik F, Ntshamane K, Tisler A, Gaikwad S
Trop Med Int Health. 2024; 29(9):768-780.
PMID: 39073229
PMC: 11368628.
DOI: 10.1111/tmi.14038.
A mouse model of TB-associated lung fibrosis reveals persistent inflammatory macrophage populations during treatment.
Boucau J, Naidoo T, Liu Y, Dasgupta S, Jain N, Castillo J
bioRxiv. 2024; .
PMID: 38895338
PMC: 11185692.
DOI: 10.1101/2024.06.04.597479.
Trends in the Notification Rates and Treatment Outcome of Tuberculosis in Shandong Province, China, 2005-2021.
Han Q, Li Y, Liu Y, Zhu X, An Q, Li Y
Infect Drug Resist. 2024; 17:1477-1490.
PMID: 38634066
PMC: 11021862.
DOI: 10.2147/IDR.S454076.
Differential decline of lung function in COPD patients according to structural abnormality in chest CT.
Lee H, Lee J, Kim Y, Jang A, Hwang Y, Lee J
Heliyon. 2024; 10(7):e27683.
PMID: 38560191
PMC: 10980934.
DOI: 10.1016/j.heliyon.2024.e27683.